BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 34332957)

  • 1. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers.
    Moloudizargari M; Asghari MH; Goel A
    Biochem Pharmacol; 2021 Oct; 192():114714. PubMed ID: 34332957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology.
    Szwedowicz U; Łapińska Z; Gajewska-Naryniecka A; Choromańska A
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles as delivery systems at nano-/micro-scale.
    Fu P; Zhang J; Li H; Mak M; Xu W; Tao Z
    Adv Drug Deliv Rev; 2021 Dec; 179():113910. PubMed ID: 34358539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology insight: Plant-derived vesicles-How far from the clinical biotherapeutics and therapeutic drug carriers?
    Cong M; Tan S; Li S; Gao L; Huang L; Zhang HG; Qiao H
    Adv Drug Deliv Rev; 2022 Mar; 182():114108. PubMed ID: 34990792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges.
    Oshchepkova A; Zenkova M; Vlassov V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
    Kooijmans SAA; de Jong OG; Schiffelers RM
    Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles in the Development of Cancer Therapeutics.
    Sun H; Burrola S; Wu J; Ding WQ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.
    Zarà M; Guidetti GF; Camera M; Canobbio I; Amadio P; Torti M; Tremoli E; Barbieri SS
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature's carriers: leveraging extracellular vesicles for targeted drug delivery.
    Chen Q; Zheng Y; Jiang X; Wang Y; Chen Z; Wu D
    Drug Deliv; 2024 Dec; 31(1):2361165. PubMed ID: 38832506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
    Ramesh D; Bakkannavar S; Bhat VR; Sharan K
    F1000Res; 2023; 12():329. PubMed ID: 37868300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.